SIGNATURES
Pursuant to the requirements of Section 13 of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized this 22nd day of March, 1996.
THE LIPOSOME COMPANY, INC. AND SUBSIDIARIES
By: /s/ Charles A. Baker
Charles A. Baker
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on the 22nd day of March,
1996 on behalf of the Registrant and in the capacities indicated.
/s/ Charles A. Baker Chairman of the Board, Chief Executive Officer
Charles A. Baker Officer and Director (Chief Executive Officer)
/S/ Brian J. Geiger Vice President Finance and Chief Financial Officer
Brian J. Geiger
/S/ Dennis A. Rodrigues Controller (Chief
Accounting Officer)
Dennis A. Rodrigues
/S/ James G. Andress Director
James G. Andress
/S/ Morton Collins Director
Morton Collins
/S/ Stuart Feiner Director
Stuart Feiner
/S/ Robert F. Hendrickson Director
Robert F. Hendrickson
/S/ Bengt Samuelsson, Dr. Director
Bengt Samuelsson, Dr.
/S/ Joseph T. Stewart, Jr. Director
Joseph T. Stewart, Jr.
/S/ Gerald Weissmann, M.D. Director
Gerald Weissmann, M.D.
/S/ Horst Witzel, Dr.-Ing. Director
Horst Witzel, Dr.-Ing.
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-29-1996
<PERIOD-END> DEC-29-1996
<CASH> 1,841
<SECURITIES> 28,269
<RECEIVABLES> 8,963
<ALLOWANCES> (1,079)
<INVENTORY> 9,904
<CURRENT-ASSETS> 48,780
<PP&E> 45,880
<DEPRECIATION> (17,588)
<TOTAL-ASSETS> 94,555
<CURRENT-LIABILITIES> 12,139
<BONDS> 0
0
0
<COMMON> 361
<OTHER-SE> 74,500
<TOTAL-LIABILITY-AND-EQUITY> 94,555
<SALES> 52,840
<TOTAL-REVENUES> 59,932
<CGS> 16,559
<TOTAL-COSTS> 77,810
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 339
<INCOME-PRETAX> (17,878)
<INCOME-TAX> 0
<INCOME-CONTINUING> (17,878)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (17,878)
<EPS-PRIMARY> (0.57)
<EPS-DILUTED> 0
</TABLE>
